RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Bridging the AI Chasm in Oncology: A Standardized Platform for In-Silico Clinical Validation of AI Models within the CHAIMELEON Project
[EN] Objective: Artificial intelligence (AI) shows promise for improving cancer management, but clinical adoption is limited by the absence of standardized validation tools. As an important step toward bridging the AI chasm, the European CHAIMELEON project addresses this gap by developing a platform for in silico validation of AI models in oncology, aligned with the EUCAIM project.
Materials and methods: We designed a web-based platform using Kubernetes microservices architecture, integrating imaging, clinical, and AI components. The backend combines a REST API, an ORTHANC-PACS, and a Keycloak/OAuth2 security layer. The frontend includes a customized OHIF DICOM viewer for oncological case review. Clinicians evaluated cases across three sequential stages: (1) Standard clinical assessment, (2) Assessment with AI predictions, and (3) Final review against clinical endpoint ground truth. The platform also collects clinicians' perceptions of AI utility, trust, workflow integration, and usability through a Likert-scale questionnaire.
Results: The platform provided efficient access to multimodal data for five cancer types. Clinicians completed structured validations, and survey responses indicated favorable perceptions: 93% found the platform intuitive, over 80% would recommend it, and agreement on AI utility exceeded 40% across most endpoints, indicating a positive reception of the AI as a supportive "second reader" tool that prompts clinical re-evaluation rather than simple consensus. Workflow impact was rated positively, underlining the potential to support clinical decision-making.
Conclusion: This platform offers a reproducible, scalable, and user-friendly environment for clinical validation of AI models in oncology. Its modular architecture allows integration of additional AI models and is designed to ensure sustainability and interoperability, fostering evidence-based AI adoption in European radiology practice., This research was supported by several grants, including European projects
such as CHAIMELEON (GA: 952172; DOI: 10.3030/952172) and EUCAIM (GA:
101100633), both funded by the European Commission. These projects have
collectively advanced the development and application of the platform and
methodology described in this manuscript, facilitating its integration into
national and European research platforms to enhance the validity and utility of
medical AI models across various AI-driven healthcare studies.